2019
DOI: 10.1016/j.jval.2019.09.781
|View full text |Cite
|
Sign up to set email alerts
|

Pcv56 Cost-Effectiveness of the Sustained-Release Paclitaxel-Eluting Eluvia Stent Compared to the Paclitaxel-Coated Zilver PTX Stent for Endovascular Treatment of Peripheral Artery Disease: A German Statutory Sickness Fund Perspective.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles